ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CDXS Codexis Inc

3.00
-0.05 (-1.64%)
Apr 30 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 272,050
Bid Price 2.90
Ask Price 3.24
News -
Day High 3.075

Low
1.45

52 Week Range

High
4.91

Day Low 2.87
Share Name Share Symbol Market Stock Type
Codexis Inc CDXS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.05 -1.64% 3.00 18:50:15
Open Price Low Price High Price Close Price Previous Close
3.01 2.87 3.075 2.91 3.05
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
2,817 272,050 US$ 2.94 US$ 799,725 - 1.45 - 4.91
Last Trade Type Quantity Price Currency
18:50:10 11 US$ 2.95 USD

Codexis Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
205.29M 70.30M - 70.14M -76.24M -1.08 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Codexis News

Date Time Source News Article
4/18/202415:05GlobeNewswire Inc.Codexis to Report First Quarter 2024 Financial Results on..
4/11/202406:05GlobeNewswire Inc.Codexis Appoints Carole Cobb, MBA, to Strategic Advisory..
3/06/202415:02Edgar (US Regulatory)Form 8-K - Current report
2/28/202415:05GlobeNewswire Inc.Codexis Reports Fourth Quarter and Fiscal Year 2023..
2/27/202411:15AllPennyStocks.comBiotech Rallied Strongly On Exclusive Licensing Agreement
2/26/202415:05GlobeNewswire Inc.Codexis Enters Exclusive Licensing Agreement for Newly..
2/26/202407:05GlobeNewswire Inc.Codexis to Participate in TD Cowen 44th Annual Health Care..
2/20/202407:05GlobeNewswire Inc.Codexis Announces Appointment of Masad Damha, PhD, and Jim..
2/16/202415:01Edgar (US Regulatory)Form 8-K - Current report
2/14/202415:51Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202415:05GlobeNewswire Inc.Codexis to Report Fourth Quarter and Fiscal Year 2023..
2/13/202415:19Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CDXS Message Board. Create One! See More Posts on CDXS Message Board See More Message Board Posts

Historical CDXS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.883.122.622.82344,9000.124.17%
1 Month3.463.4852.612.95356,605-0.46-13.29%
3 Months2.614.912.533.48575,3100.3914.94%
6 Months1.604.911.512.90674,6241.4087.50%
1 Year3.894.911.452.62840,375-0.89-22.88%
3 Years23.6042.011.4510.35774,712-20.60-87.29%
5 Years19.7142.011.4512.11627,325-16.71-84.78%

Codexis Description

Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products. The firm's products and services include Screening and Evolution services, Enzymes, Screening Kits. It also develops protein engineering and biocatalyst platforms such as Codeevolver, Ketoreductases, Transminases, Imine reductases, etc. The company operates in two business segments namely Performance Enzymes and Novel Biotherapeutics. It generates maximum revenue from the Performance Enzymes segment.

Your Recent History

Delayed Upgrade Clock